Business Context and Reporting Period
Company: Scully Royalty Ltd. (Cayman Islands corporation)
Filing Type: Form 6-K (Proxy Statement for Annual and Extraordinary General Meeting)
Reporting Period: The filing relates to the Annual and Extraordinary General Meeting scheduled for December 29, 2021. Financial data referenced in the compensation tables pertains to the fiscal year ended December 31, 2020.
Business Overview: The Company is a royalty company. The filing focuses on corporate governance matters, specifically the election of directors, ratification of auditors, and a significant amendment to the 2017 Equity Incentive Plan.
Key Financial Metrics
Revenue, Profit, Cash Flow, Margins, Debt, Liquidity: The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity for the current or prior periods. This document is a proxy statement and does not contain the full financial statements.
Capital Structure:
- Outstanding Shares: 13,684,622 Common Shares as of the record date (November 22, 2021).
- Stock Dividends: A 9% stock dividend was paid on May 31, 2021. An 8% stock dividend was declared, payable November 30, 2021.
Executive Compensation (Fiscal Year 2020):
- Michael J. Smith (Executive Chairman): Total compensation of $789,376 (Salary: $480,235; All Other: $309,141).
- Samuel Morrow (President, CEO, CFO): Total compensation of $623,536 (Salary: $496,622; All Other: $126,914).
- Directors' Fees: Aggregate of approximately $0.6 million paid to non-executive directors in 2020.
Auditor Fees (Fiscal Year 2020):
- Audit Fees (Smythe LLP): $442,156.
- Audit-Related, Tax, and Other Fees: $0.
Material Changes and Corporate Actions
Equity Incentive Plan Amendment:
- The Company proposes to amend the 2017 Equity Incentive Plan to increase the total number of Common Shares available for awards from 677,364 to 2,239,027.
- Annual grant limits for Covered Employees are proposed to increase from 70,000 to 400,000 shares.
- Annual grant limits for new participants are proposed to increase from 80,000 to 425,000 shares.
- Concurrent with the amendment, the Board approved an option grant of 1,307,000 shares (including 400,000 to the CEO and 34,000 to each non-employee director), contingent on shareholder approval.
Leadership Changes:
- Samuel Morrow was appointed President, CEO, and Director on May 1, 2021, replacing Michael J. Smith, who continued as Executive Chairman.
Auditor Change:
- Smythe LLP was appointed as the independent auditor on December 21, 2020, succeeding BDO LLP.
Guidance, Outlook, and Risks
Management Commentary:
- The proposed Equity Plan amendment is intended to provide sufficient shares to satisfy equity grant requirements until the 2023 annual general meeting.
- Compensation philosophy focuses on aligning executive pay with long-term shareholder value and performance.
Risks and Contingencies:
- Equity Dilution: The proposed amendment would increase the number of shares available for awards by approximately 11% of the Company's outstanding shares (adjusted for dividends).
- Employment Agreements: Samuel Morrow's employment agreement includes severance provisions. Termination without cause could result in a payment of approximately US$608,000. Termination in contemplation of a Change in Control could result in a lump sum of approximately US$912,500.
- Change in Control: The Equity Plan contains a "double trigger" acceleration provision for employees and officers upon a Change in Control combined with termination without cause or for good reason.
Investor Verification Checklist
- Equity Plan Approval: Verify the outcome of the shareholder vote on the 2017 Equity Incentive Plan amendment, as the 1.3 million option grants are contingent on this approval.
- Dilution Impact: Assess the impact of the proposed increase in the share reserve (to 2.24 million shares) on existing shareholders.
- Executive Compensation: Review the specific terms of Samuel Morrow's employment agreement regarding severance and change-in-control payouts.
- Auditor Independence: Confirm the continued appointment of Smythe LLP and review their independence disclosures.
- Stock Dividend Execution: Verify the completion of the 8% stock dividend declared for November 30, 2021.